Votes: MD HB484 | 2026 | Regular Session

Bill Title: Corporate Income Tax - Addition Modification - Direct-to-Consumer Pharmaceutical Advertising

Sponsorship: Partisan Bill (Democrat 11)

Status: (Introduced) 2026-01-23 - Hearing 2/12 at 1:00 p.m. [HB484 Detail]

Text: Latest bill text (Introduced) [PDF]

Voting Records

ChamberVoteDateYeaNayNVAbsTotalResultSourceView
No roll call record information currently on file.
States not producing parsable votes may be available as images in Supplemental Documents.

feedback